This inventor holds 4 USPTO granted patents and 8 published patent applications and 3 EPO patents. Top assignees: Children's Medical Center Corporation, Icahn School of Medicine at Mount Sinai, The General Hospital Corporation. Active years: 2018-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Brookline, MA (US) (2018)
- New York, NY (US) (2022)
Company Filing History:
2 out of 1,072 
2 out of 536 
2 out of 3,071 
Years Active: 2018-2025
Title: Lior Zangi: Innovator in RNA Technology
Introduction
Lior Zangi is a prominent inventor based in New York, NY (US), known for his significant contributions to the field of RNA technology. He holds a total of 4 patents, showcasing his innovative approach to gene expression modulation.
Latest Patents
Zangi's latest patents include groundbreaking work on efficient protein expression in vivo using modified RNA (mod-RNA). This invention focuses on synthetic, modified RNAs and their application in vivo to modulate gene expression, particularly in myocytes, cardiomyocytes, and tumors. Another notable patent is the development of a cell-specific expression regulatory system. This system enables the transcription of a protein of interest in a cell-specific manner, which can reactivate proliferation in adult or neonatal cardiomyocytes or insulin-producing beta cells.
Career Highlights
Throughout his career, Lior Zangi has worked with esteemed institutions such as the Icahn School of Medicine at Mount Sinai and The General Hospital Corporation. His work has significantly advanced the understanding of RNA technology and its applications in medicine.
Collaborations
Zangi has collaborated with notable colleagues, including Ajit Magadum and Kenneth R. Chien, further enhancing the impact of his research and innovations.
Conclusion
Lior Zangi's contributions to RNA technology and gene expression modulation have established him as a leading inventor in his field. His innovative patents and collaborations continue to influence advancements in medical research and applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile